Active	Status	Sponsor type	Region	Phase	Filter
8 Active 3 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bullard, Michael
NCT05285553: MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms	Recruiting	N/A	900	US	MiSight 1 Day, Proclear 1 day	Coopervision, Inc.	Myopia	06/27	06/27
Smith, Brittany
NCT06179108: Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia	Active, not recruiting	2	350	US	LB-102	LB Pharmaceuticals Inc.	Schizophrenia	12/24	05/25
NCT05758883: Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)	Completed	N/A	196	US		AcuFocus, Inc.	Cataract, Presbyopia	02/24	02/24
REFRESH, NCT06792708: Observational Study of LUMRYZ in Narcolepsy	Recruiting	N/A	75	US	LUMRYZ	Avadel	Narcolepsy	07/25	07/25
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27
Hansen, Brock
Apricity-A, NCT06100939: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus	Recruiting	3	400	US	Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment	Epion Therapeutics	Keratoconus	10/25	10/25
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27
Wilcox, Michael
NCT05758883: Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)	Completed	N/A	196	US		AcuFocus, Inc.	Cataract, Presbyopia	02/24	02/24
Freise, Veronica
No trials found